Regulatory changes are accelerating globally. Today, it’s the European Union’s Medical Device Regulations (EU MDR) and phasing out ethylene oxide (EtO) sterilization. Tomorrow, it will be strict cybersecurity and artificial intelligence requirements.
Medical device companies that excel in proactive compliance and remediation will have a competitive advantage.
They can choose to build an in-house competency and/or establish strong partnerships with expert advisors. Each approach brings advantages and challenges. The choice will depend on a company’s long-term strategic priorities, expertise, size, budget, and more. Here, several considerations for making an informed decision.
Build an in-house competency | Partner with consultant(s) | |
Control |
|
|
Cost |
|
|
Timing |
|
|
Knowledge base |
|
|
Training |
|
|
Resources |
|
|
Tools |
|
|
Culture |
|
|
Sustainability |
|
|
If your company doesn’t have the experience and expertise to manage the next big regulatory program, or if you’re working to build an in-house remediation competency, download Apply Lessons from EU MDR to Upcoming Regulatory Changes.
Carl Manthe is a Director in IPM’s Los Angeles office and the company’s Medical Technology industry lead. Carl has been managing complex projects for more than 30 years and has extensive experience leading teams in product development, business process optimization, change management, capital expansion, quality, portfolio management, and business integration projects.
"*" indicates required fields
Carl Manthe is a Director in IPM’s Los Angeles office and the company’s Medical Technology industry lead. Carl has been managing complex projects for more than 30 years and has extensive experience leading teams in product development, business process optimization, change management, capital expansion, quality, portfolio management, and business integration projects.